Merck Pharma GmbH & Co. KGaA (Quality control and batch release)

The drug is used for intensive therapy and initial treatment of akinetic crisis during acute exacerbations of parkinsonism symptoms. It is also used in hospital settings to improve the ability to focus attention (vigilance) in patients in post-comatose states.

Dosage form: solution for infusion

ATC: N04BB01